Scientists claim to have developed a “universal” cancer vaccine that can train patients’ own bodies to seek out and destroy tumour cells.

A team from Tel Aviv University and drug company Vaxil Biotheraputics say the therapy targets a molecule found in 90 per cent of all cancers, and could soon pave the way for a universal injection that allows patients’ immune systems to fight off common cancers including breast and prostate cancer.